Production of isoprenoid pharmaceuticals by engineered microbes
Top Cited Papers
- 15 November 2006
- journal article
- perspective
- Published by Springer Nature in Nature Chemical Biology
- Vol. 2 (12) , 674-681
- https://doi.org/10.1038/nchembio836
Abstract
Throughout human history, natural products have been the foundation for the discovery and development of therapeutics used to treat diseases ranging from cardiovascular disease to cancer. Their chemical diversity and complexity have provided structural scaffolds for small-molecule drugs and have consistently served as inspiration for medicinal design. However, the chemical complexity of natural products also presents one of the main roadblocks for production of these pharmaceuticals on an industrial scale. Chemical synthesis of natural products is often difficult and expensive, and isolation from their natural sources is also typically low yielding. Synthetic biology and metabolic engineering offer an alternative approach that is becoming more accessible as the tools for engineering microbes are further developed. By reconstructing heterologous metabolic pathways in genetically tractable host organisms, complex natural products can be produced from inexpensive sugar starting materials through large-scale fermentation processes. In this Perspective, we discuss ongoing research aimed toward the production of terpenoid natural products in genetically engineered Escherichia coli and Saccharomyces cerevisiae.Keywords
This publication has 85 references indexed in Scilit:
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Artemisia annua L. (Asteraceae) trichome‐specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisininFEBS Letters, 2006
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005
- Cloning, Heterologous Expression, and Characterization of a Phenylalanine Aminomutase Involved in Taxol BiosynthesisJournal of Biological Chemistry, 2004
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Purification and Characterization of an Enzyme Involved in Biochemical Transformation of Arteannuin B to Artemisinin from Artemisia annuaBiochemical and Biophysical Research Communications, 2001
- New Approach to Multiply Deuterated Isoprenoids Using Triply Engineered Escherichia coli and Its Potential as a Tool for Mechanistic EnzymologyJournal of the American Chemical Society, 2001
- The Regulation of Activity of Main Mevalonic Acid Pathway Enzymes: Farnesyl Diphosphate Synthase, 3-Hydroxy-3-methylglutaryl-CoA Reductase, and Squalene Synthase in Yeast Saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 2000
- Isolation and Identification of Dihydroartemisinic Acid from Artemisia annua and Its Possible Role in the Biosynthesis of ArtemisininJournal of Natural Products, 1999
- Expression of an active phytoene synthase from Erwinia uredovora and biochemical properties of the enzymeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998